| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0447.2012.01835.X |
| P8608 | Fatcat ID | release_bch7dipmovhv3g7jjdjvcsyiiy |
| P698 | PubMed publication ID | 22321029 |
| P2093 | author name string | T Becker | |
| K Frasch | |||
| W Schepp | |||
| S Jaeger | |||
| T Steinert | |||
| R Kilian | |||
| P Weiser | |||
| T Messer | |||
| G Längle | |||
| G W Eschweiler | |||
| C Pfiffner | |||
| D Croissant | |||
| P2860 | cites work | Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics | Q24811190 |
| The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. | Q30492614 | ||
| Effectiveness of switching from antipsychotic polypharmacy to monotherapy. | Q30542484 | ||
| Cost of antipsychotic polypharmacy in the treatment of schizophrenia | Q33327172 | ||
| The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements | Q33566124 | ||
| National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
| A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation | Q34298891 | ||
| Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations | Q34941330 | ||
| Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. | Q36914354 | ||
| Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials | Q37137001 | ||
| Does the addition of a second antipsychotic drug improve clozapine treatment? | Q37147547 | ||
| Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study | Q37220015 | ||
| Polypharmacy with second-generation antipsychotics: a review of evidence | Q37341522 | ||
| Polypharmacy in schizophrenia | Q37669107 | ||
| Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies | Q37670925 | ||
| Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. | Q37723434 | ||
| Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses | Q38499772 | ||
| Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients | Q39874856 | ||
| International consensus study of antipsychotic dosing. | Q43111655 | ||
| Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study | Q43246864 | ||
| A successful antipsychotic combination trial. Quo Vadis? | Q45048384 | ||
| Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid program | Q45078085 | ||
| 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia | Q45275037 | ||
| Hospital use of antipsychotic drugs: polytherapy. | Q46863430 | ||
| Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy | Q50112124 | ||
| Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. | Q51909276 | ||
| The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial. | Q51927623 | ||
| Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. | Q51942046 | ||
| Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics | Q55969829 | ||
| Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile – European Version: EPSILON Study 8 | Q57471129 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 372-381 | |
| P577 | publication date | 2012-02-09 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment | |
| P478 | volume | 125 |
| Q42180852 | Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities. |
| Q26800235 | Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice |
| Q48492684 | Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits |
| Q44057877 | Description of long-term polypharmacy among schizophrenia outpatients |
| Q40099162 | Does one size really fit all? The effectiveness of a non-diagnosis-specific integrated mental health care program in Germany in a prospective, parallel-group controlled multi-centre trial |
| Q33747710 | Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing |
| Q33755467 | Effectiveness and efficiency of integrated mental health care programmes in Germany: study protocol of an observational controlled trial |
| Q43982680 | Effects of Affective and Anxiety Disorders on Outcome in Problem Gamblers Attending Routine Cognitive-Behavioural Treatment in South Australia. |
| Q44080860 | Happy new year 2013. |
| Q37592998 | Long-term Benzodiazepine Treatment in Patients with Psychotic Disorders Attending a Mental Health Service in Rural Greece |
| Q39432205 | Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion |
| Q39062177 | Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward |
| Q88127770 | Pharmacological treatment for schizoaffective disorder : A comparison with schizophrenia and bipolar disorder |
| Q37582708 | Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria |
| Q38058534 | Psychopathological long-term outcome of schizophrenia -- a review |
| Q38232547 | Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review |
| Q87831274 | Rehospitalization risk of former voluntary and involuntary patients with schizophrenia |
| Q38239613 | Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy |
Search more.